専用ページ186 Targeting gut microbiota for diabetic nephropathy treatmentの詳細情報
Targeting gut microbiota for diabetic nephropathy treatment。Frontiers | Targeting gut microbiota for diabetic nephropathy。Nanoreactor-based catalytic systems for therapeutic applications。Epigallocatechin-3-gallate therapeutic potential in human diseases。No.076 9300円